MedTechIndexBETA
The MedTechIndex Briefing

Keep up with MedTechIndex.

A weekly note from Blair, new companies added to the directory, and meaningful updates to existing profiles.

Confirm your email to join. Email privacy

Companies / Hyperice
Medical device company profile

Hyperice

Irvine-based recovery and rehabilitation technology company with a mixed portfolio of FDA-cleared Normatec devices and consumer health products.

Manufacturer / DeveloperOrthopedics & MusculoskeletalRehabilitation & RecoveryCommercial stage · Mixed portfolio
Headquarters🇺🇸Irvine, California, United States
Founded2011
Commercial statusCommercially availableU.S. direct and retail sales; international distribution varies by product.
Employees51–200 [46]LinkedIn company-size range · Checked 2026-10-15
Estimated revenueNot confirmed
Disclosed fundingOver US$100 million [47]Growth-capital facility · Jul 2023
Official websitehyperice.com ↗

Company overview

Hyperice develops recovery and movement technology for consumers, athletes and professional settings. Its portfolio spans Normatec compression, Hypervolt percussion, Venom heat and vibration, Hyperice X contrast therapy, and Vyper and Hypersphere tools. The company is headquartered in Irvine, California.

Hyperice acquired NormaTec in 2020, adding a compression-device portfolio with FDA records filed under NormaTec legal entities. Current Normatec systems have product-specific clearances; those decisions do not establish a company-wide regulatory status or extend to every Hyperice product.

The business sells directly and through retailers, with Nike also serving as a product-development and distribution partner. Its consumer availability and professional-market connections support inclusion in recovery and rehabilitation technology; athlete endorsements and commercial partnerships are separate from clinical evidence.

[1][28][29][45][46][47]

Leadership

2 people
Jim HuetherChief Executive Officer [43]
Anthony KatzFounder & President [1][2]

Products & regulatory status How does MedTechIndex get this information?

Summary

The four mapped Normatec records are Class II, IRP air-pressure massagers. Reviewed labeling supports temporary minor muscle-pain relief and temporary circulation increase; it is not a broad clearance for athletic performance, disease treatment or every product sold by Hyperice. Other product families require separate regulatory mapping. [31][32][25][13][7][27][23][3]

No matching FDA recall event was identified in the completed company/applicant, linked-identifier and product-name searches. [19][15]

Regulatory snapshot How to read this snapshot

U.S. FDA
4
510(k) clearances
0
De Novo grants
0
PMA approvals
0
Recall events

Latest recorded source review: 2026-10-20.

Commercial portfolio snapshot

Documented commercial product families.

Pneumatic compression massager

Normatec 3 ↗

Current air-compression system; K220217 is a Class II clearance under the NormaTec Industries applicant name. [25][31]

FDA-cleared

Listed in current U.S. catalog; availability varies by model and market.

Portable compression massager

Normatec Go ↗

Calf-compression product with K221666 clearance. [25]

FDA-cleared

Listed in current U.S. catalog; availability varies by model and market.

Wireless compression massager

Normatec Elite Legs ↗

Current Elite leg system mapped to the Normatec Elite K240122 record. [25][32]

FDA-cleared

Listed in current U.S. catalog; availability varies by model and market.

Compression massager

Normatec Elite Hips ↗

Current hip-compression product mapped to Normatec Elite Hip K251905. [25]

FDA-cleared

Listed in current U.S. catalog; availability varies by model and market.

Percussion massage

Hypervolt ↗

Current percussion family includes Hypervolt 3, 3 Pro and Go 3. Exact FDA classification and exemption basis have not been established in this review. [23]

Marketed · regulatory scope varies

Listed in current U.S. catalog; availability varies by model and market.

Thermal / contrast therapy

Hyperice X ↗

Hot, cold and contrast-therapy family, including current X 2 knee and shoulder products. Regulatory status requires model-specific confirmation. [22]

Marketed · regulatory scope varies

Listed in current U.S. catalog; availability varies by model and market.

View 3 additional documented product families
Heat and vibration

Venom ↗

Wearable heat-and-vibration family; its marketed recovery applications are not treated as evidence of FDA clearance. [26]

Marketed · regulatory scope varies

Listed in current U.S. catalog; availability varies by model and market.

Vibration recovery tools

Vyper / Hypersphere ↗

Vibrating roller and ball families marketed for muscle recovery and massage. [27]

Marketed · regulatory scope varies

Listed in current U.S. catalog; availability varies by model and market.

Wearable recovery technology

Nike x Hyperice Hyperboot / Air Zoom Hyperslide ↗

Co-developed footwear: Hyperboot combines heat and compression; Hyperslide combines cushioning, heat and vibration. No Normatec clearance is automatically extended to these products. [24][1][2]

Marketed · regulatory scope varies

Listed in current U.S. catalog; availability varies by model and market.

Products with unconfirmed commercial availability

Historical authorization records

Earlier Normatec systems — current mapping unresolved ↗

MVP, PCD, Pulse and prescription variants have historical FDA records. Their current marketing status and ownership/SKU continuity require confirmation; they are excluded from the current portfolio totals.

Commercial availability not established

Current commercial availability not established.

Commercial development

Recent commercial work spans the Hypervolt 3 line, Hyperice X 2, Normatec Elite Hips and Nike collaboration products. These are commercial releases, not automatically investigational medical-device programs. Modality-level recovery research is referenced separately; a complete product-specific clinical assessment is pending. [43][2][30]

Activity & Milestones

7 events
2026-07-27 · Partnership / launch

Air Zoom Hyperslide announced

Nike introduced the heat-and-vibration recovery slide, with availability scheduled for September 29 in selected markets. Current product listings support commercial availability. [2][24]

2025-09-18 · Regulatory

Normatec Elite Hip cleared

FDA cleared K251905 under NormaTec Industries, LP. The current Hyperice catalog lists Elite Hips. [25][42]

2025-04-17 · Partnership / launch

Nike announces Hyperboot retail availability

Nike announced North American retail availability beginning May 17, 2025, through both brands and selected retail partners. [1]

2023-07-12 · Financing

US$100M+ growth capital facility announced

Atlas Credit Partners announced a growth financing facility. Facility size does not establish the amount drawn or represent annual revenue or an equity funding total. [44]

2020-10-08 · Funding

Strategic investment round announced

Main Street Advisors and SC.Holdings led a round including sports organizations and athlete investors. The company announcement reported a US$700 million valuation; this is historical valuation, not revenue or current enterprise value. [48]

2020-03-05 · Acquisition

Hyperice acquires NormaTec

Acquisition adds pneumatic-compression technology and combines operations. The announcement describes a Boston operating base alongside Irvine headquarters. [45]

2011 · Company

Company founding year stated as 2011

The current company About page and LinkedIn profile state 2011. Some historical coverage uses 2010; that discrepancy remains noted for confirmation. [28][46]

48 Cited Sources

Accessed 10/29/2026

[3] FDA 510(k) database — research search ↗FDA / openFDA · regulatory record
[4] FDA K013436 — NORMATEC PCD ↗U.S. Food and Drug Administration · regulatory record
[5] FDA K112890 — NORMATEC MVP ↗U.S. Food and Drug Administration · regulatory record
[6] FDA K160608 — NormaTec Pulse and NormaTec Pulse Pro ↗U.S. Food and Drug Administration · regulatory record
[7] FDA K161346 — NormaTec PCD-T and PCD-B ↗U.S. Food and Drug Administration · regulatory record
[8] FDA K183169 — Pulse 2.0, Pulse Pro 2.0 ↗U.S. Food and Drug Administration · regulatory record
[9] FDA K183328 — Pulse Rx 2.0, Pulse Pro Rx 2.0 ↗U.S. Food and Drug Administration · regulatory record
[10] FDA K220217 — Normatec 3 ↗U.S. Food and Drug Administration · regulatory record
[11] FDA K221666 — Normatec Go ↗U.S. Food and Drug Administration · regulatory record
[12] FDA K240122 — Normatec Elite ↗U.S. Food and Drug Administration · regulatory record
[13] FDA K251905 — Normatec Elite Hip ↗U.S. Food and Drug Administration · regulatory record
[14] FDA De Novo database — research search ↗FDA / openFDA · regulatory record
[17] FDA PMA database — research search ↗FDA / openFDA · regulatory record
[20] FDA UDI database — research search ↗FDA / openFDA · regulatory record
[44] Atlas announces US$100M+ growth capital facility — July 2023 ↗Atlas Credit Partners / Club Insider · press release
[45] Hyperice acquires NormaTec — March 5, 2020 ↗Hyperice / GlobeNewswire · press release
Company research

Compare companies

Privacy choices

Your saved-company and comparison preferences are stored separately. Changing analytics preferences does not clear them.

About cookies and privacy